Drug Manufacturers - General Industry

Drug Manufacturers - General industry analysis: EL7 Score and the best stocks ranked by value, profitability, and momentum.

EL7 Score

89Strong

6 of 152

P/E 25.8 vs period average 23.3 Richer than its history

Total stocks19

Total Market Cap$4.4T

Median P/E25.8x

Median Net Margin12.0%

Value

Growth

Best Stocks in Drug Manufacturers - General

Ranked among 16 stocks with a market cap above $500M. Smaller companies are excluded from the ranking.

Rank	Company	Price	Change	P/E	Fwd P/E	Value	Growth	Quality	Safety	Capital Return	EL7 Score
1/16	LLYEli Lilly and	$1279.14	+0.4%	42.9	28.5	10	100	97	67	45	92
2/16	NVONovo Nordisk A/S	$39.13	+0.2%	9.8	—	76	32	81	71	81	68
3/16	BMYBristol-Myers Squibb	$61.61	+0.2%	13.6	10.3	79	22	46	24	84	63
4/16	GSKGSK	$51.10	+0.7%	16.2	—	68	46	43	37	76	62
5/16	SNYSanofi	$41.79	+0.5%	11.8	—	94	62	22	68	61	59
6/16	NVSNovartis	$153.81	+1.8%	23.2	15.9	52	38	76	40	82	57
7/16	ABBVAbbVie	$286.79	+0.4%	81.0	18.3	19	70	75	14	55	52
8/16	AZNAstraZeneca	$172.06	+0.3%	25.8	15.2	45	78	57	46	63	52
9/16	OGNOrganon	$13.74	-0.1%	17.6	3.8	92	6	38	2	56	38
10/16	PFEPfizer	$29.79	-0.8%	39.2	10.3	65	5	35	21	23	35

Page 1 of 2

Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.

ETFs with exposure to this sector

Funds that track the sector and each fund's exposure to it.

Fund	Exposure	Assets	Expense	Holdings
IBBiShares Biotechnology ETF	100.0%	$11B	0.44%	243
VHTVanguard Health Care ETF	100.0%	$22B	0.09%	411
IHIiShares U.S. Medical Devices ETF	99.7%	$4B	0.37%	49
XLVState Street Health Care Select Sector SPDR ETF	99.1%	$48B	0.08%	61

The percentage is the sector's share of the fund's assets, per the latest available data.